Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Biotricity Inc. (BTCY) vs NeuroOne Medical Technologies Corporation (NMTC)

Biotricity Inc. and NeuroOne Medical Technologies Corporation are both Medical Devices companies. NeuroOne Medical Technologies Corporation is the larger, with a market value of $12.1M against $10.9M — 1.1× the size. Biotricity Inc. grew revenue faster over the last twelve months: 13.4% against −1.67%. Biotricity Inc. has the higher net margin (−21.0% vs −78.6%) and the higher return on invested capital (0.00% vs −287.1%). Across the 17 metrics below, Biotricity Inc. leads on 11 and NeuroOne Medical Technologies Corporation on 6.

Valuation

Metric BTCY NMTC Medical Devices median
P/E n/m n/m 22.18
P/S 0.10 1.22 2.70
P/B n/m 3.06 2.46
Price to free cash flow 12.27 n/m 22.53
EV/EBITDA 11.70 n/m 11.78
EV/Sales 1.70 1.00 2.38
Earnings yield (200.00%) (67.67%) (8.22%)
Free cash flow yield 8.15% (62.16%) (7.80%)

Profitability

Metric BTCY NMTC Medical Devices median
Gross margin 81.47% 55.65% 56.01%
Operating margin 9.56% (83.43%) (15.03%)
Net margin (21.00%) (78.63%) (20.40%)
Free cash flow margin 0.99% (75.63%) (7.24%)
Return on equity 9.75% (124.66%) (15.32%)
Return on assets (57.12%) (87.56%) (19.72%)
Return on invested capital 0.00% (287.08%) (10.33%)

Growth

Metric BTCY NMTC Medical Devices median
Revenue growth (TTM) 13.41% (1.67%) 8.80%
EPS growth (last fiscal year) 80.00% 80.43% —
Revenue growth, 5-year CAGR 36.43% 44.41% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BTCY NMTC Medical Devices median
Debt to equity (0.75) 0.00 0.07
Current ratio 0.15 2.84 2.50
Net debt to EBITDA 10.85 1.74 0.49

Dividend

Metric BTCY NMTC Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric BTCY NMTC Medical Devices median
Market cap 10.87m 12.11m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack